A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD

NCT06709014 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

760

Enrollment

INDUSTRY

Sponsor class

Conditions

Early Alzheimers Disease

Interventions

DRUG: buntanetap/posiphen
DRUG: Placebo

Sponsor

Annovis Bio Inc.

Collaborators

[object Object]
[object Object]